Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1189

1.

Natural killer-dendritic cell cross-talk in cancer immunotherapy.

Kalinski P, Mailliard RB, Giermasz A, Zeh HJ, Basse P, Bartlett DL, Kirkwood JM, Lotze MT, Herberman RB.

Expert Opin Biol Ther. 2005 Oct;5(10):1303-15. Review.

PMID:
16197336
2.

Helper role of NK cells during the induction of anticancer responses by dendritic cells.

Kalinski P, Giermasz A, Nakamura Y, Basse P, Storkus WJ, Kirkwood JM, Mailliard RB.

Mol Immunol. 2005 Feb;42(4):535-9. Review.

PMID:
15607810
3.

Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function.

Mailliard RB, Son YI, Redlinger R, Coates PT, Giermasz A, Morel PA, Storkus WJ, Kalinski P.

J Immunol. 2003 Sep 1;171(5):2366-73.

4.

Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells.

Schnurr M, Scholz C, Rothenfusser S, Galambos P, Dauer M, Röbe J, Endres S, Eigler A.

Cancer Res. 2002 Apr 15;62(8):2347-52.

5.

The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.

Ojima T, Iwahashi M, Nakamura M, Matsuda K, Naka T, Nakamori M, Ueda K, Ishida K, Yamaue H.

Int J Oncol. 2006 Apr;28(4):947-53.

PMID:
16525645
6.

Helper roles of NK and CD8+ T cells in the induction of tumor immunity. Polarized dendritic cells as cancer vaccines.

Kalinski P, Nakamura Y, Watchmaker P, Giermasz A, Muthuswamy R, Mailliard RB.

Immunol Res. 2006;36(1-3):137-46. Review.

PMID:
17337774
7.

Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens.

Tosi D, Valenti R, Cova A, Sovena G, Huber V, Pilla L, Arienti F, Belardelli F, Parmiani G, Rivoltini L.

J Immunol. 2004 May 1;172(9):5363-70.

8.

Dendritic cells in innate immune responses against HIV.

Servet C, Zitvogel L, Hosmalin A.

Curr Mol Med. 2002 Dec;2(8):739-56. Review.

PMID:
12462394
9.

The bidirectional crosstalk between human dendritic cells and natural killer cells.

Wehner R, Dietze K, Bachmann M, Schmitz M.

J Innate Immun. 2011;3(3):258-63. doi: 10.1159/000323923. Epub 2011 Mar 11. Review.

PMID:
21411969
10.

Natural-killer cells and dendritic cells: "l'union fait la force".

Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E.

Blood. 2005 Oct 1;106(7):2252-8. Epub 2005 Jun 2. Review.

12.

Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.

Tanaka F, Hashimoto W, Okamura H, Robbins PD, Lotze MT, Tahara H.

Cancer Res. 2000 Sep 1;60(17):4838-44.

13.

DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction.

Adam C, King S, Allgeier T, Braumüller H, Lüking C, Mysliwietz J, Kriegeskorte A, Busch DH, Röcken M, Mocikat R.

Blood. 2005 Jul 1;106(1):338-44. Epub 2005 Mar 15.

14.

Effector and regulatory events during natural killer-dendritic cell interactions.

Moretta L, Ferlazzo G, Bottino C, Vitale M, Pende D, Mingari MC, Moretta A.

Immunol Rev. 2006 Dec;214:219-28. Review.

PMID:
17100887
15.

Reciprocal activating interaction between natural killer cells and dendritic cells.

Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G.

J Exp Med. 2002 Feb 4;195(3):327-33.

16.

The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions.

Gerosa F, Gobbi A, Zorzi P, Burg S, Briere F, Carra G, Trinchieri G.

J Immunol. 2005 Jan 15;174(2):727-34.

17.

Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer.

Arina A, Murillo O, Dubrot J, Azpilikueta A, Alfaro C, Pérez-Gracia JL, Bendandi M, Palencia B, Hervás-Stubbs S, Melero I.

Expert Opin Biol Ther. 2007 May;7(5):599-615. Review.

PMID:
17477799
18.

Dendritic cell-induced activation of adaptive and innate antitumor immunity.

van den Broeke LT, Daschbach E, Thomas EK, Andringa G, Berzofsky JA.

J Immunol. 2003 Dec 1;171(11):5842-52. Erratum in: J Immunol. 2004 Jul 1;173(1):695.

19.

Impaired dendritic cell functions because of depletion of natural killer cells disrupt antigen-specific immune responses in mice: restoration of adaptive immunity in natural killer-depleted mice by antigen-pulsed dendritic cell.

Yoshida O, Akbar F, Miyake T, Abe M, Matsuura B, Hiasa Y, Onji M.

Clin Exp Immunol. 2008 Apr;152(1):174-81. doi: 10.1111/j.1365-2249.2008.03601.x. Epub 2008 Feb 25.

20.

Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection.

Jinushi M, Takehara T, Tatsumi T, Kanto T, Miyagi T, Suzuki T, Kanazawa Y, Hiramatsu N, Hayashi N.

J Immunol. 2004 Nov 15;173(10):6072-81.

Supplemental Content

Support Center